当前位置:
X-MOL 学术
›
Microb. Drug Resist.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Multidrug-Resistant Infections and Outcome of Critically Ill Patients with Coronavirus Disease 2019: A Single Center Experience
Microbial Drug Resistance ( IF 2.6 ) Pub Date : 2021-09-09 , DOI: 10.1089/mdr.2020.0489 Arta Karruli 1 , Filomena Boccia 1 , Massimo Gagliardi 1 , Fabian Patauner 1 , Maria Paola Ursi 1 , Pino Sommese 1 , Rosanna De Rosa 2 , Patrizia Murino 2 , Giuseppe Ruocco 3 , Antonio Corcione 2 , Roberto Andini 4 , Rosa Zampino 4, 5 , Emanuele Durante-Mangoni 1, 4
Microbial Drug Resistance ( IF 2.6 ) Pub Date : 2021-09-09 , DOI: 10.1089/mdr.2020.0489 Arta Karruli 1 , Filomena Boccia 1 , Massimo Gagliardi 1 , Fabian Patauner 1 , Maria Paola Ursi 1 , Pino Sommese 1 , Rosanna De Rosa 2 , Patrizia Murino 2 , Giuseppe Ruocco 3 , Antonio Corcione 2 , Roberto Andini 4 , Rosa Zampino 4, 5 , Emanuele Durante-Mangoni 1, 4
Affiliation
Background: The aim of this study was to assess the drivers of multidrug-resistant (MDR) bacterial infection development in coronavirus disease 2019 (COVID-19) and its impact on patient outcome.
中文翻译:
2019 年冠状病毒病危重患者的多重耐药感染和预后:单一中心经验
背景:本研究的目的是评估 2019 年冠状病毒病(COVID-19)中耐多药(MDR)细菌感染发展的驱动因素及其对患者预后的影响。
更新日期:2021-09-15
中文翻译:
2019 年冠状病毒病危重患者的多重耐药感染和预后:单一中心经验
背景:本研究的目的是评估 2019 年冠状病毒病(COVID-19)中耐多药(MDR)细菌感染发展的驱动因素及其对患者预后的影响。